![]() AB Science AB Science is a pharmaceutical company that engages in the discovery, development, and commercialization of protein kinase inhibitors for use in human and veterinary medicines. | Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | ![]() Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients. | |
Founding Date | Founding Date 2001 | Founding Date 1978 | Founding Date 1951 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Paris, FR HQ | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | |
Employees | Employees 40 | Employees 7,605 | Employees 8,5201% increase |
Valuation ($) | Valuation ($) 70.2 m | Valuation ($) 26.7 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) €1.2m (FY, 2025) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods €196k (FY, 2025) | Cost of goods $2.4b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit €978k (FY, 2025) | Gross profit $7.5b (FY, 2025) | Gross profit N/A |
Net income | Net income (€1.6m) (FY, 2025) | Net income $1.3b (FY, 2025) | Net income N/A |
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company
Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.
View company